Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Alexander

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Experimental Medicine|April 1, 1991
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in miceH R Alexander, G M Doherty, C M Buresh, et al.
Surgery|August 1, 1991
Pentoxifylline suppression of tumor necrosis factor gene transcriptionG M Doherty, J C Jensen, H R Alexander, et al.
Journal of Surgical Oncology|July 1, 1985
Percutaneous subclavian catheterization for prolonged systemic chemotherapyW R Thompson, H R Alexander, A J Martin, et al.
Surgery|February 15, 2001
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancerD L Bartlett, S K Libutti, W D Figg, et al.
Annals of Surgery|September 1, 1994
Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinomaD L Fraker, J A Norton, H R Alexander, et al.
Annals of Surgical Oncology|January 1, 1996
Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexiaK G Billingsley, D L Fraker, G Strassmann, et al.
Journal of Virology|October 3, 2001
Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapyY Hu, J Lee, J A McCart, et al.
The Journal of Experimental Medicine|September 1, 1993
Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemiaM I Block, M Berg, M J McNamara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liverH R Alexander, D L Bartlett, S K Libutti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liverH R Alexander, S K Libutti, D L Bartlett, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Experimental Medicine|April 1, 1991
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in miceH R Alexander, G M Doherty, C M Buresh, et al.
Surgery|August 1, 1991
Pentoxifylline suppression of tumor necrosis factor gene transcriptionG M Doherty, J C Jensen, H R Alexander, et al.
Journal of Surgical Oncology|July 1, 1985
Percutaneous subclavian catheterization for prolonged systemic chemotherapyW R Thompson, H R Alexander, A J Martin, et al.
Surgery|February 15, 2001
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancerD L Bartlett, S K Libutti, W D Figg, et al.
Annals of Surgery|September 1, 1994
Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinomaD L Fraker, J A Norton, H R Alexander, et al.
Annals of Surgical Oncology|January 1, 1996
Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: possible cellular mechanisms of cancer cachexiaK G Billingsley, D L Fraker, G Strassmann, et al.
Journal of Virology|October 3, 2001
Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapyY Hu, J Lee, J A McCart, et al.
The Journal of Experimental Medicine|September 1, 1993
Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemiaM I Block, M Berg, M J McNamara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liverH R Alexander, D L Bartlett, S K Libutti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liverH R Alexander, S K Libutti, D L Bartlett, et al.
Pageof 14